ADTX

ADiTx Therapeutics Stock Price

3.37
-0.23 (-6.39%)
3.37
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
ADiTx Therapeutics Inc ADTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.23 -6.39% 3.37 16:13:58
Open Price Low Price High Price Close Price Prev Close
3.71 3.30 3.6799 3.355 3.60
Bid Price Ask Price Spread News
3.36 3.37 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,557 2,455,841 $ 3.47 $ 8,515,729 6,184,699 1.62 - 10.40
Last Trade Time Type Quantity Stock Price Currency
16:15:57 61 $ 3.36 USD

ADiTx Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 41.38M 12.28M 10.46M $ - $ - -1.05 -5.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 12.70%

more financials information »

ADiTx Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.356.732.333.7736,441,7351.0243.4%
1 Month2.236.732.053.667,899,0521.1451.12%
3 Months1.936.731.863.313,575,2341.4474.61%
6 Months4.2910.401.624.282,693,836-0.92-21.45%
1 Year5.2810.401.624.262,411,877-1.91-36.17%
3 Years5.2810.401.624.262,411,877-1.91-36.17%
5 Years5.2810.401.624.262,411,877-1.91-36.17%

ADiTx Therapeutics Description

ADiTx Therapeutics Inc is a pre-clinical stage, life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.


Your Recent History
NASDAQ
ADTX
ADiTx Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.